missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ IL-18 Polyclonal Antibody
Goat Polyclonal Antibody
Marca: Invitrogen™ PA547344
Questo articolo non è restituibile.
Consulta la politica di reso
Descrizione
This antibody detects rhesus macaque IL-18/IL-1F4 in direct ELISAs and Western blots. In Western blots, approximately 10% cross-reactivity with recombinant mouse IL-18, recombinant rat IL-18, and recombinant porcine IL-18 is observed. Reconstitute at 0.2 mg/mL in sterile PBS. Endoxin level is <0.10 EU per 1 μg of the antibody by the LAL method.
The protein encoded by this gene is a proinflammatory cytokine. This cytokine can induce the IFN-gamma production of T cells. The combination of this cytokine and IL12 has been shown to inhibit IL4 dependent IgE and IgG1 production, and enhance IgG2a production of B cells. IL-18 binding protein can specifically interact with this cytokine, and thus negatively regulate its biological activity.
Specifica
| IL-18 | |
| Polyclonal | |
| Unconjugated | |
| IL18 | |
| cytokine; iboctadekin; IFN-gamma-inducing factor; IGIF; il 18; IL-1 gamma; IL18; IL-18; IL1F4; IL-1g; ILN; interferon gamma inducing factor; interferon gamma-inducing factor; interferon-gamma-inducing factor; Interleukin; interleukin 18; interleukin 18 (interferon-gamma-inducing factor); interleukin-1 gamma; Interleukin18; Interleukin-18; interleukin-18 proprotein; interleukin-18-like protein; MGC12320 | |
| Goat | |
| Antigen affinity chromatography | |
| RUO | |
| 3606, 574151 | |
| -20°C, Avoid Freeze/Thaw Cycles | |
| Lyophilized |
| ELISA, Neutralization, Western Blot, Immunocytochemistry | |
| 0.2 mg/mL | |
| PBS with 5% trehalose and No Preservative | |
| Q14116 | |
| IL18 | |
| E. coli-derived recombinant rhesus macaque IL-18/IL-1F4 Tyr37-Asp193. | |
| 100 μg | |
| Primary | |
| Human, Rhesus Macaque | |
| Antibody | |
| IgG |
Correzione del contenuto del prodotto
Fornite il vostro feedback sul contenuto del prodotto compilando il modulo sottostante.
Titolo del prodotto
Individuate un'opportunità di miglioramento?Condividi una correzione di contenuto